Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,messageBoardId,marketState,shortName,market,exchangeDataDelayedBy,exchange,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,EWL.DE,3634500000,621636992,225300000,,545500000,,489500000,374500000,1041700000,441900000,441900000,,-2500000,,,,56000000,1376000000,934100000,334300000,103600000,,489500000,489500000,327000000,1578700000,2528800000,5133300000,149300000,7662100000,640100000,233300000,5392700000,983500000,1171800000,-2478200000,295800000,1312800000,886200000,190500000,-159600000,1530400000,3322900000,1014200000,248400000,700300000,595400000,759500000,144600000,-252400000,94100000,-329500000,-1200000,-59000000,-600000,54200000,135000000,-111900000,-2600000,526100000,35800000,-7800000,15000000,-46400000,-100000,-70400000,-69300000,2436700000,en-US,US,EQUITY,False,Delayed Quote,EUR,1618935304,1634673600,1635192000,88.197876,1.132,7.492,95.01444,4.825554,0.050787583,80.836975,19.003021,0.23507833,62738853888,13.326214,15,Europe/Berlin,CEST,7200000,2,0.38206038,99.84 - 100.65,99.46,100.15,100.75,finmb_411220,POST,EDWARDS LIFESCIENCES,de_market,0,GER,False,False,99.84,1630504564,0.37999725,100.65,100.65,99.84,443,XETRA,Edwards Lifesciences Corporation,USD,245,248,35.0,0.5397903,64.84 - 102.9,-3.0600052,-0.029737659,64.84,102.9,1.07,,,102.9,64.84,95.01,80.84,245,248,621.64M,,617.9M,0.74%,86.36%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Jun 30, 2021",29.69%,31.37%,13.71%,32.60%,4.93B,7.91,48.80%,3.31B,1.67B,1.46B,1.13,,1.56B,2.51,684.2M,13.33,3.75,7.49,1.44B,566.76M,Value,92614,Healthcare,14900,5,5,"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",Irvine,949 250 2500,CA,3,1609372800,1625097600,8,United States,http://www.edwards.com,86400,4,One Edwards Way,949 250 2525,Medical Devices
t-1,EWL.DE,3157300000,621636992,207000000,,389300000,,338200000,330800000,923200000,385400000,385400000,,-2500000,,,,51100000,1216600000,831200000,293400000,3900000,,338200000,338200000,330300000,1496800000,2555300000,4658400000,137900000,7213700000,637500000,229100000,4903200000,1094000000,1170800000,-2379100000,334800000,1174200000,799000000,209300000,-172400000,1506400000,3069200000,802200000,156400000,664300000,595200000,767900000,150400000,59400000,-9300000,-49700000,-400000,-274300000,-27000000,31600000,-9300000,-302600000,14200000,300500000,32400000,-3100000,2500000,-89500000,-2900000,39100000,-106000000,2270200000,en-US,US,EQUITY,False,Delayed Quote,EUR,1618935304,1634673600,1635192000,88.197876,1.132,7.492,95.01444,4.825554,0.050787583,80.836975,19.003021,0.23507833,62738853888,13.326214,15,Europe/Berlin,CEST,7200000,2,0.38206038,99.84 - 100.65,99.46,100.15,100.75,finmb_411220,POST,EDWARDS LIFESCIENCES,de_market,0,GER,False,False,99.84,1630504564,0.37999725,100.65,100.65,99.84,443,XETRA,Edwards Lifesciences Corporation,USD,245,248,35.0,0.5397903,64.84 - 102.9,-3.0600052,-0.029737659,64.84,102.9,1.07,,,102.9,64.84,95.01,80.84,245,248,621.64M,,617.9M,0.74%,86.36%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Jun 30, 2021",29.69%,31.37%,13.71%,32.60%,4.93B,7.91,48.80%,3.31B,1.67B,1.46B,1.13,,1.56B,2.51,684.2M,13.33,3.75,7.49,1.44B,566.76M,Value,92614,Healthcare,14900,5,5,"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",Irvine,949 250 2500,CA,3,1609372800,1625097600,8,United States,http://www.edwards.com,86400,4,One Edwards Way,949 250 2525,Medical Devices
t-2,EWL.DE,3069700000,621636992,195700000,,356100000,,309500000,338900000,895400000,360800000,360800000,,-15800000,,,,46600000,1191700000,830900000,296300000,-4700000,,309500000,309500000,331400000,1438100000,2662800000,4574300000,154200000,7237100000,636400000,208200000,4565000000,1101200000,1173200000,-2065200000,350500000,1183200000,893900000,230900000,-161100000,1489400000,3091000000,801600000,219400000,602800000,595000000,802300000,196500000,-138900000,-30600000,-259900000,900000,41400000,9200000,37000000,170900000,-200000,-10600000,400000000,32600000,-7500000,-2400000,51100000,3700000,17900000,-113200000,2197100000,en-US,US,EQUITY,False,Delayed Quote,EUR,1618935304,1634673600,1635192000,88.197876,1.132,7.492,95.01444,4.825554,0.050787583,80.836975,19.003021,0.23507833,62738853888,13.326214,15,Europe/Berlin,CEST,7200000,2,0.38206038,99.84 - 100.65,99.46,100.15,100.75,finmb_411220,POST,EDWARDS LIFESCIENCES,de_market,0,GER,False,False,99.84,1630504564,0.37999725,100.65,100.65,99.84,443,XETRA,Edwards Lifesciences Corporation,USD,245,248,35.0,0.5397903,64.84 - 102.9,-3.0600052,-0.029737659,64.84,102.9,1.07,,,102.9,64.84,95.01,80.84,245,248,621.64M,,617.9M,0.74%,86.36%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Jun 30, 2021",29.69%,31.37%,13.71%,32.60%,4.93B,7.91,48.80%,3.31B,1.67B,1.46B,1.13,,1.56B,2.51,684.2M,13.33,3.75,7.49,1.44B,566.76M,Value,92614,Healthcare,14900,5,5,"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",Irvine,949 250 2500,CA,3,1609372800,1625097600,8,United States,http://www.edwards.com,86400,4,One Edwards Way,949 250 2525,Medical Devices
t-3,EWL.DE,2707900000,621636992,195500000,,364300000,,325200000,307200000,859900000,357200000,357200000,,-800000,,,,39100000,1140900000,783700000,281000000,7100000,,325200000,325200000,332400000,1381600000,2590500000,4210300000,143900000,6800800000,635000000,171500000,4255500000,1078300000,1170000000,-2061800000,353200000,1024000000,846300000,215200000,-157900000,1365800000,2980400000,599000000,271300000,671700000,594900000,773300000,162500000,-15300000,81400000,-126300000,-500000,34000000,-110300000,36100000,120500000,-1400000,-3300000,216100000,25600000,-7700000,-19000000,-30700000,-200000,18600000,-103300000,2134100000,en-US,US,EQUITY,False,Delayed Quote,EUR,1618935304,1634673600,1635192000,88.197876,1.132,7.492,95.01444,4.825554,0.050787583,80.836975,19.003021,0.23507833,62738853888,13.326214,15,Europe/Berlin,CEST,7200000,2,0.38206038,99.84 - 100.65,99.46,100.15,100.75,finmb_411220,POST,EDWARDS LIFESCIENCES,de_market,0,GER,False,False,99.84,1630504564,0.37999725,100.65,100.65,99.84,443,XETRA,Edwards Lifesciences Corporation,USD,245,248,35.0,0.5397903,64.84 - 102.9,-3.0600052,-0.029737659,64.84,102.9,1.07,,,102.9,64.84,95.01,80.84,245,248,621.64M,,617.9M,0.74%,86.36%,,,,,,,,,,,0.00%,,,,,"Dec 31, 2020","Jun 30, 2021",29.69%,31.37%,13.71%,32.60%,4.93B,7.91,48.80%,3.31B,1.67B,1.46B,1.13,,1.56B,2.51,684.2M,13.33,3.75,7.49,1.44B,566.76M,Value,92614,Healthcare,14900,5,5,"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",Irvine,949 250 2500,CA,3,1609372800,1625097600,8,United States,http://www.edwards.com,86400,4,One Edwards Way,949 250 2525,Medical Devices
